Adhera Therapeutics Eulerpool News

Adhera Therapeutics Eulerpool News

Adhera Therapeutics Stock News

Adhera Therapeutics is being monitored by journalists and investors worldwide. We gather the latest Adhera Therapeutics news here.

• February 12 ·

  GuruFocus
  Adhera Therapeutics Inc Annual Shareholders Meeting Transcript
• November 27 ·

  MarketWatch
  Biodexa Pharma Shares Double After Licensing Deal for Tolimidone
• November 27 ·

  MarketWatch
  Biodexa Enters Worldwide Licensing Deal for Tolimidone
• January 25 ·

  Yahoo
  Adhera Therapeutics to Collaborate with Alberta Diabetes Institute, University of Alberta to Initiate Clinical Trial of MLR-1023 in Type 1 Diabetes
• December 5 ·

  Seeking Alpha
  Adhera Therapeutics files for Nasdaq uplisting, $35M offering
• October 7 ·

  DowJones
  U.S. stocks end sharply lower after strong jobs report keeps Fed on hiking path, but post gain for week
• October 3 ·

  DowJones
  Bear Market Playbook - MarketWatch
• September 26 ·

  DowJones
  He ‘house hacked’ his way to wealth, and now plans to build a mansion - MarketWatch
• September 23 ·

  DowJones
  Building Generational Wealth - MarketWatch
• September 19 ·

  Yahoo
  Adhera Therapeutics Announces CEO, Senior Management Changes, Plans for NASDAQ Uplist